JOHANNESBURG (Reuters) -Turmoil in the wake of U.S. President Donald Trump's tariff hikes has abruptly stalled emerging market sovereign debt sales in
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that
In a wide ranging interview with Fortune, the former Treasury Secretary also says we're already seeing the first signals of a possible recession.
(Reuters) -Morgan Stanley beat first-quarter profit estimates on Friday, helped by record equity trading and strong wealth management results. U.S.
